CEO

Leads LTG strategy, team building, and operations; exits in cannabis; led teams of 50 plus; raised $10+ million in biopharma

Chief Science Officer

Leads chemistry and product development; former Novo Nordisk R&D lead; expert in API production and formulation

Chief Medical Officer

Leads clinical development; former Director of Spine Research University of Minnesota; 50 plus peer reviewed publications

Medical Science Liaison

Primary pain medicine communicator; physiatrist focused on musculoskeletal pain; University of Toronto training

Director of Pain Medicine

Leads clinical pain guidance, interventional pain specialist; Stanford fellowship; Harvard MPH

Head of Drug Discovery

A globally recognized authority in physical and computational chemistry, Dr. Chass serves as a Reader (Professor) at Queen Mary University of London. He specializes in the quantum mechanical modeling of complex molecular systems, bridging the gap between theoretical physics and tangible therapeutic breakthroughs in longevity.

Chief Computational Solutions Architect

With a PhD in Medicinal Chemistry and deep expertise in ab initio methods, Dr. Setiadi leads the technical architecture of our discovery platform. He is a specialist in translating quantum chemical theory into scalable computational frameworks, ensuring our simulations achieve subatomic precision at an industrial pace.

Investor Relations

Leads institutional investor relations; facilitated 1B+ in healthcare and tech transactions; founder of TLT Capital

Chemist

Leads synthesis and chemistry communication; 10 plus years in organic chemistry; small molecule and psychedelic specialist

Chief Growth Officer

Key role in team building, lab oversight and initial capital raise; managed 50M plus in assets; serial entrepreneur

Translational medicine and precision psychiatry expert; Assistant Professor at Johns Hopkins; former Lieber Institute investigator; NIMH trained neuroscientist; President Elect of the American Society for Clinical Pharmacology and Therapeutics.

In vivo pharmacology lead; heads the In Vivo Pharmacology Lab at the Lieber Institute; Assistant Professor of Pharmacology at Johns Hopkins; specializes in PK PD and behavioral biomarker models.

Commercialization and launch advisor; led multiple global pharma launches; former Takeda VP, Shiire

Global innovation and R and D leader; former Head of Innovation and External R&D at Dr. Reddy’s Laboratories; led multinational partnerships; currently Director of R and D Program Management at BioNTech.

Clinical pain and neuromodulation specialist; Associate Professor of Anesthesiology and Pain Medicine at UC San Diego; board certified in PM and R and pain medicine; focuses on chronic and neuropathic pain.